Epidemiology and long term survival of gastric carcinoma in the French district of Finistère between 1984 and 1995

Gastroenterologie Clinique et Biologique

Volumn 29, Issue 1, 2005, Pages 23-32

  Fayçal, Joseph ^a   Bessaguet, Christophe ^a   Nousbaum, Jean Baptiste ^a   Cauvin, Jean Michel ^a   Cholet, Franck ^a   Bideau, Karine ^a   Robaszkiewicz, Michel ^a   Gouérou, Hervé ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; FRANCE; HUMAN; LINITIS PLASTICA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PROGNOSIS; STOMACH CARCINOMA; TUMOR VOLUME;

EID: 13844250344     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(05)80690-6     Document Type: Article

References (38)

1. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Sci Publ 1993;1-806.
2. Faivre J, Benhamiche AM. Le cancer de l'estomac: du nouveau? Gastroenterol Clin Biol 1995;19:793-6.
3. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
4. Benhamiche AM, Colonna M, Aptel I, Launoy G, Schaffer P, Arveux P, et al. Estimation de l'incidence des cancers du tube digestif par région. Gastroenterol Clin Biol 1999;23:1040-7.
5. Le Page M, Cauvin JM, Le Dreau G, Nousbaum JB, Enard L, Gourlaouen A, et al. Prise en charge thérapeutique et survie de l'adénocarcinome gastrique dans le département du Finistère entre 1984 et 1989. Gastroenterol Clin Biol 1995;19:804-10.
6. Bouvier AM, Esteve J, Milry E, Clinard F, Bonithon-Kopp C, Faivre J. Trends in gastric cancer incidence in a well-defined French population by time period and birth cohort. Eur J Cancer Prev 2002;11:221-7.
7. Cauvin JM, Nousbaum JB, Gouerou H. Le cancer superficiel de l'estomac à l'aube du XXI siècle. Gastroenterol Clin Biol 1998;22:3-5.
8. Arsene D, Gignoux M, Pottier D, Rougereau A, Even C, Dao T, et al. Le cancer superficiel de l'estomac dans le département du Calvados de 1978 à 1990.. Gastroenterol Clin Biol 1998;22:6-12.
9. Benhamiche AM, Faivre J, Tazi MA, Darsouni R, Villing AL, Couillault C. Le cancer superficiel de l'estomac: évolution de leurs caractéristiques sur une période de 20 ans dans une population. Gastroenterol Clin Biol 1998;22:13-8.
10. Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997;41:142-50.
11. Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 1998;34:2167-75.
12. Rapport d'activité du Comité national des registres 1992-1996. Paris: INSERM 1997.
13. Watanabe H, Jass JR, Sobin LH. Histological typing of gastric and oesophageal tumors. WHO International Histological Classification of Tumors, Berlin. Springer-Verlag 1990.
14. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
15. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981;11:127-39.
16. Estève J, Benhamou E, Raymond L. Statistical Methods in Descriptive Epidemiology. IARC 1993.
17. Yang PC, Davis S. Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States. 1973-1982. Int J Epidemiol 1988;17:293-7.
18. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-56.
19. Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, et al. The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer 1993;72:330-40.
20. Desoubeaux N, Le Prieur A, Launoy G, Maurel J, Lefevre H, Guillois JM, et al. Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: a population based study. Eur J Cancer Prev 1999;8:479-86.
21. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
22. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
23. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
24. Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 2000;35 Suppl 12:84-9.
25. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996;23:281-91.
26. Meyer C, Lozac'h P, Rohr S, Topar P, Youssef C. Gastric cancer: the French survey. Acta Gastroenterol Belg 2002;65:161-5.
27. Arsene D, Chomontowski J, Pottier D, Rougereau A, Launoy G, Gignoux M. Epidémiologie et pronostique des carcinomes gastriques dans le département du Calvados, étude sur 10 ans. Gastroenterol Clin Biol 1995;19:797-803.
28. Antonioli DA, Cady B. Changing aspects of gastric adenocarcinoma. N Engl J Med 1984;310:1538.
29. Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma. Cancer 1982;50:775-81.
30. Yurugi E, Koga S, Kaibara N, Nishidoi H, Kimura O, Sumi K. Chronological trends in the pathological characteristics of gastric cancer in young and aged patients. Dig Surg 1988;5:142-147.
31. Yang XF, Yang L, Mao XY, Wu DY, Zhang SM, Xin Y. Pathobiological behavior and molecular mechanism of signet ring cell carcinoma and mucinous adenocarcinoma of the stomach: a comparative study. World J Gastroenterol 2004;10:750-4.
32. Maehara Y, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, Korenaga D, et al. Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection. Surg Gynecol Obstet 1992;175:13-6.
33. Msika S, Benhamiche AM, Rat P, Faivre J. Pronostic à long terme du cancer gastrique dans la population de Côte d'Or. Gastroenterol Clin Biol 2000;24:649-55.
34. Msika S, Tazi MA, Benhamiche AM, Couillault C, Harb M, Faivre J. Population-based study of diagnosis, treatment and prognosis of gastric cancer. Br J Surg 1997;84:1474-8.
35. Msika S, Benhamiche AM, Tazi MA, Rat P, Faivre J. Improvement of operative mortality after curative resection for gastric cancer: population-based study. World J Surg 2000;24:1137-42.
36. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 2000;36:390-6.
37. Rougier P, Ducreux M, Mahjoubi M, Pignon JP, Bellefqih S, Oliveira J, et al. Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer 1994;30A:1263-9.
38. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.